ACRS - Aclaris Therapeutics EPS beats by $0.01 beats on revenue May, 07 2020 05:08 PM Aclaris Therapeutics Inc. Aclaris Therapeutics (NASDAQ:ACRS): Q1 GAAP EPS of -$0.37 beats by $0.01.More news on: Aclaris Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...